The next generation of BONE DENSITY diagnosis
empowering clinicians to curb the silent disease
At the forefront of innovation in the management of bone disease, Echolight aims to bring this new & advanced technology to clinics around the world. By doing so, the impact on undiagnosed osteoporosis and prevention of fracture can help patients, the community and healthcare resources achieve a better outcome.
echolight - Proudly distributed by cortex health
Cortex Health (est 2013) is a Melbourne based distributor of highly specialised medical products into Australia. The company is dedicated to bringing in only the latest innovation from around the world to meet unmet clinical needs.
Imagination. Knowledge. Quality.
Echolight is using Innovation to accurately measure BMD (g/cm2), T-score, Z-score and fragility via REMS technology.
Knowledge has been gained since 2015, throughout the pivotal studies and with worldwide experience in using the device in clinical practice.
Regulatory excellence has resulted in certifications in Australia (TGA Registered device Sept 2021) as well as Europe (CE), US (FDA) as we as manufacturing excellence (UNI CEI EN ISO 9001)
Echolight developed REMS technology in collaboration with the National Council of Research (Italy). National & International multi-centre pivotal clinical studies consistently demonstrated the alignment to DXA in the diagnosis of osteoporosis as well as measuring BMD (g/cm2), T-score, Z-Score, Fragility score at the primary axial sites (lumbar spine & femoral neck).
DEVELOPED BY an International scientific and clinical advisory board
If you are a healthcare professional and would like to enquire about Echolight devices or having an Echolight scanning day in your clinic, please contact us.